Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Table of Contents May 1, 2024
  • Information for Readers May 1, 2024
    Communications regarding original articles and editorial management should be addressed to Ronald L. Dalman, MD, and Thomas L. Forbes, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 312-334-2355; fax: 312-334-2320; e-mail: JVASCSURG@vascularsociety.org. Information for authors appears in the January and July issues, at www.jvascsurg.org, and at jvs.editorialmanager.com. […]
  • Submitting a successful NIH career development award for the vascular surgeon scientist May 1, 2024
    Obtaining an NIH career development award (“K award”) is often an important step in establishing a career as a vascular surgeon scientist. The application and review process is competitive, involves many steps, and may be confusing to the prospective applicant. Further, there are requirements involving mentors and the applicant’s institution. This article, authored completely by […]
    S. Minc, J.M. Ruddy, C.W. Hicks, T.T. Nguyen, A.T. Obi, N.H. Osborne, T.-W. Tan, A.A. Ucuzian, S.K. Shah
  • Editorial Board May 1, 2024
  • Type IIIb Endoleaks: Fabric Perforations of Explanted New Generation Endoprostheses May 1, 2024
    To analyse explanted endografts (EGs) and describe fabric degradation responsible for type IIIb endoleaks.
    D. Vakhitov, J. Grandhomme, S. Kuntz, L. Christ, N. Neumann, F. Heim, N. Chakfé, A. Lejay, Explants Collaborator Group
  • Morphological Changes of the Ovarian Vein in Pelvic Venous Disorders May 1, 2024
    The management of pelvic venous disorders (PeVD) remains controversial. Open surgical and endovascular methods are currently used for treatment, but there are few data in the literature on the morphology and histology of the ectatic ovarian vein (OV). This study aimed to explore the histomorphological changes in a dilated OV in patients with PeVD and […]
    A. Nykonenko, A. Trailin, Z. Lazarashvili, R.M. Proczka, B. Havrylenko, O. Nykonenko
  • Effect of junctional reflux on the venous clinical severity score in patients with insufficiency of the great saphenous vein (JURY study) May 1, 2024
    Effective treatment options are available for chronic venous insufficiency associated with superficial venous reflux. Although many patients with C2 and C3 disease based on the CEAP (Clinical-Etiological-Anatomical-Pathophysiological) classification have combined great saphenous vein (GSV) and saphenofemoral junction (SFJ) reflux, some may not have concomitant SFJ reflux. Several payors have determined that symptom severity in patients […]
    C. Vemuri, K.D. Gibson, P.J. Pappas, M. Sadek, W. Ting, A.T. Obi, N.J. Mouawad, Y. Etkin, A.P. Gasparis, T. McDonald, S. Sahoo, J.D. Sorkin, B.K. Lal